Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 15;277(1-2):189-92.
doi: 10.1016/j.jneuroim.2014.09.021. Epub 2014 Oct 5.

Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study

Affiliations

Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study

Chiara Briani et al. J Neuroimmunol. .

Abstract

Circulating Pentraxin 3 (PTX3) and vascular endothelial growth factor (VEGF) levels were measured longitudinally (mean follow-up 2 years) by ELISA in 6 patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes (POEMS) syndrome and 16 controls. Expression of PTX3 was also assessed (immunohistochemistry) on sural nerve biopsies from POEMS and vasculitic neuropathy patients. No correlation was found between PTX3 and VEGF levels in POEMS or controls. Sural nerve biopsies from vasculitic neuropathy patients, but not those from POEMS syndrome, showed strong PTX3 staining. PTX3, expression of vessel inflammation/remodeling, and VEGF, crucial pro-angiogenic cytokine, appear to be independently regulated in POEMS syndrome.

Keywords: POEMS syndrome; Pentraxin 3; Polyneuropathy; Vascular endothelial growth factor (VEGF); Vasculitis.

PubMed Disclaimer

Comment in

  • Evaluation of pentraxin-3 in POEMS syndrome.
    Agilli M, Aydin FN. Agilli M, et al. J Neuroimmunol. 2015 Jan 15;278:136. doi: 10.1016/j.jneuroim.2014.12.015. Epub 2014 Dec 19. J Neuroimmunol. 2015. PMID: 25595262 No abstract available.

LinkOut - more resources